
Nucleic Acid Testing Market by Indication (Cancer, Forensic Testing, Genetic & Mitochondrial Disorders), Product (Consumables, Nucleic Acid Test Kits), Technique, End User - Global Forecast 2024-2030
Description
Nucleic Acid Testing Market by Indication (Cancer, Forensic Testing, Genetic & Mitochondrial Disorders), Product (Consumables, Nucleic Acid Test Kits), Technique, End User - Global Forecast 2024-2030
The Nucleic Acid Testing Market size was estimated at USD 3.43 billion in 2023 and expected to reach USD 3.79 billion in 2024, at a CAGR 10.30% to reach USD 6.83 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Nucleic Acid Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Nucleic Acid Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Nucleic Acid Testing Market, highlighting leading vendors and their innovative profiles. These include 23andMe, Inc., Abbott Laboratories, Agilent Technologies, Inc., ARUP Laboratories, Asuragen Inc., Beckman Coulter, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Biomérieux SA, Cepheid, F. Hoffmann-La Roche Ltd., Gen-Probe, Inc., Illumina, Inc., Novartis AG, and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage
This research report categorizes the Nucleic Acid Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:
Indication
Cancer
Forensic Testing
Genetic & Mitochondrial Disorders
Infectious Disease
Product
Consumables
Nucleic Acid Test Kits
Technique
Probe Amplification Systems
Signal Amplification
Target Amplification Systems
End User
Hospitals
Pathology Laboratories
Research Institutes
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Nucleic Acid Testing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Nucleic Acid Testing Market?
3. What are the technology trends and regulatory frameworks in the Nucleic Acid Testing Market?
4. What is the market share of the leading vendors in the Nucleic Acid Testing Market?
5. Which modes and strategic moves are suitable for entering the Nucleic Acid Testing Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
188 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Nucleic Acid Testing Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising cases of cancer and other infectious diseases
- 5.1.1.2. Increased commercialization of human genetic tests
- 5.1.1.3. Exponential need in pandemic control and eradication
- 5.1.2. Restraints
- 5.1.2.1. Huge expenditure on R&D
- 5.1.3. Opportunities
- 5.1.3.1. Attractive funding space and government support to expand testing capabilities
- 5.1.3.2. Increasing government approvals and reimbursements available
- 5.1.4. Challenges
- 5.1.4.1. Complex instrumentation and technology
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Nucleic Acid Testing Market, by Indication
- 6.1. Introduction
- 6.2. Cancer
- 6.3. Forensic Testing
- 6.4. Genetic & Mitochondrial Disorders
- 6.5. Infectious Disease
- 7. Nucleic Acid Testing Market, by Product
- 7.1. Introduction
- 7.2. Consumables
- 7.3. Nucleic Acid Test Kits
- 8. Nucleic Acid Testing Market, by Technique
- 8.1. Introduction
- 8.2. Probe Amplification Systems
- 8.3. Signal Amplification
- 8.4. Target Amplification Systems
- 9. Nucleic Acid Testing Market, by End User
- 9.1. Introduction
- 9.2. Hospitals
- 9.3. Pathology Laboratories
- 9.4. Research Institutes
- 10. Americas Nucleic Acid Testing Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Nucleic Acid Testing Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Nucleic Acid Testing Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. 23andMe, Inc.
- 14.1.2. Abbott Laboratories
- 14.1.3. Agilent Technologies, Inc.
- 14.1.4. ARUP Laboratories
- 14.1.5. Asuragen Inc.
- 14.1.6. Beckman Coulter, Inc.
- 14.1.7. Becton Dickinson and Company
- 14.1.8. Bio-Rad Laboratories, Inc.
- 14.1.9. Biomérieux SA
- 14.1.10. Cepheid
- 14.1.11. F. Hoffmann-La Roche Ltd.
- 14.1.12. Gen-Probe, Inc.
- 14.1.13. Illumina, Inc.
- 14.1.14. Novartis AG
- 14.1.15. Thermo Fisher Scientific Inc.
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. NUCLEIC ACID TESTING MARKET RESEARCH PROCESS
- FIGURE 2. NUCLEIC ACID TESTING MARKET SIZE, 2023 VS 2030
- FIGURE 3. NUCLEIC ACID TESTING MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. NUCLEIC ACID TESTING MARKET DYNAMICS
- FIGURE 7. NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
- FIGURE 8. NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 10. NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
- FIGURE 12. NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
- FIGURE 14. NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. NUCLEIC ACID TESTING MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. NUCLEIC ACID TESTING MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.